ResearcherChina Pharmaceutical UniversityActive in the last 2 years
Epiphane K. Silli
Matched on ORCID iD 0009-0000-0243-1566; OpenAlex author ID A5092699598. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2023: 1 paper · 2024: 1 paper · 2025: 1 paper
Papers 3
- The function of microRNA related to cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.bcp.2025.116849↗
- Growth inhibition of pancreatic cancer by targeted delivery of gemcitabine via fucoidan-coated pH-sensitive liposomes. Co-author DOI 10.1016/j.ijbiomac.2024.134517↗
- Liposomal nanostructures for Gemcitabine and Paclitaxel delivery in pancreatic cancer. Co-author DOI 10.1016/j.ejpb.2023.09.014↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zhenjiang Zheng · 2 shared papers, 2024–2025 · strength 0.38
- Paper The function of microRNA related to cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. DOI 10.1016/j.bcp.2025.116849↗
- Paper Growth inhibition of pancreatic cancer by targeted delivery of gemcitabine via fucoidan-coated pH-sensitive liposomes. DOI 10.1016/j.ijbiomac.2024.134517↗
- Chunlu Tan · 2 shared papers, 2024–2025 · strength 0.38
- Paper The function of microRNA related to cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. DOI 10.1016/j.bcp.2025.116849↗
- Paper Growth inhibition of pancreatic cancer by targeted delivery of gemcitabine via fucoidan-coated pH-sensitive liposomes. DOI 10.1016/j.ijbiomac.2024.134517↗
- Ying Wang · 2 shared papers, 2023–2024 · strength 0.37
- Jia Chen · 1 shared paper, 2025 · strength 0.20
- Ying Wang · 1 shared paper, 2025 · strength 0.20
- Yaohui Fang · 1 shared paper, 2025 · strength 0.20
- Yonghua Chen · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.